David F. Lehmann

Mississippi Mud No More: Cost‐Effectiveness of Pharmacokinetic Dosage Adjustment of Vancomycin to Prevent Nephrotoxicity

William Darko, Joseph J. Medicis, Adrienne Smith et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2003 · 84 citations

Anticonvulsant usage is associated with an increased risk of procarbazine hypersensitivity reactions in patients with brain tumors

David F. Lehmann, Tracy E. Hurteau, Nancy Newman et al. · Clinical Pharmacology & Therapeutics · 1997 · 50 citations

Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy

Robin L. Davis, David F. Lehmann, Christine A. Stidley et al. · Antimicrobial Agents and Chemotherapy · 1991 · 39 citations · Full text

Medicine, Amikacin Pharmacokinetic Parameters, Pharmacology +8

Every Error a Treasure: Improving Medication Use with a Nonpunitive Reporting System

David F. Lehmann, Nancy E. Page, Karen Kirschman et al. · The Joint Commission Journal on Quality and Patient Safety · 2007 · 36 citations

Health Policy, Drug Information System, Patient Safety +7

Polymorphisms and the Pocketbook: The Cost‐Effectiveness of Cytochrome P450 2C19 Genotyping in the Eradication of <i>Helicobacter pylori</i> Infection Associated with Duodenal Ulcer

David F. Lehmann, Joseph J. Medicis, Patricia D. Franklin · The Journal of Clinical Pharmacology · 2003 · 32 citations

Cyp2c19 Genotype, Molecular Epidemiology, Genotype Test +17